BUND FINANCE

BUND FINANCE › Stocks › IQV

IQVIA Holdings Inc. (IQV)

NYSE · Stock price, chart and technical analysis

US$257.84+0.2400 (+0.09%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:01 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$257.60
OpenUS$260.62
Day rangeUS$254.33 – US$260.62
52-week rangeUS$154.50 – US$284.50
Market capUS$42.49B
Volume1.40M
50-day averageUS$267.32
200-day averageUS$211.33
Beta1.16

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$13.9BUS$14.4BUS$15.0BUS$15.4BUS$16.3B
Net incomeUS$966.0MUS$1.1BUS$1.4BUS$1.4BUS$1.4B
EPS (diluted)4.955.727.297.497.84
Gross margin33.5%34.9%35.0%34.9%33.3%
Operating margin10.0%12.5%13.2%14.3%13.4%
Net margin7.0%7.6%9.1%8.9%8.3%
Free cash flowUS$2.3BUS$1.6BUS$1.5BUS$2.1BUS$2.1B
Total debtUS$12.4BUS$13.0BUS$13.9BUS$14.2BUS$16.2B
CashUS$1.4BUS$1.2BUS$1.4BUS$1.7BUS$2.0B

Compound annual growth: revenue 4.1% · net income 8.9% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E31.3x35.4x27.1x
EV / EBITDA15.7x17.9x16.5x
Operating margin13.4%—3.6%
Net margin8.1%—-0.0%
Debt / equity3.56—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About IQVIA Holdings Inc.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
CEOAri Bousbib
Employees94,000
IPO date2013-05-09

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence …

www.iqvia.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice